Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epstein-Barr virus (EBV) envelope glycoprotein gH is a critical component of the viral entry machinery. It forms a heterodimeric complex with glycoprotein L (gL), and together, they are essential for mediating the fusion of the viral envelope with host cell membranes, enabling EBV to enter target cells. This process is fundamental for infection of both B lymphocytes and epithelial cells.
Neutralizing antibodies can block gH/gL mediated membrane fusion, preventing viral entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epstein-Barr Virus Envelope Glycoprotein H (gH).